IDEXX Laboratories Inc (IDXX)
Debt-to-capital ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 622,883 | 694,387 | 775,205 | 858,492 | 698,910 |
Total stockholders’ equity | US$ in thousands | 1,484,530 | 608,737 | 689,992 | 632,088 | 177,473 |
Debt-to-capital ratio | 0.30 | 0.53 | 0.53 | 0.58 | 0.80 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $622,883K ÷ ($622,883K + $1,484,530K)
= 0.30
The debt-to-capital ratio for Idexx Laboratories, Inc. has shown a fluctuating trend over the last five years. In 2019, the ratio was relatively high at 0.85, indicating that a significant portion of the company's capital structure was funded by debt. However, there has been a decreasing trend in the ratio since then, reaching 0.39 at the end of 2023.
This downward trend in the debt-to-capital ratio suggests that the company has been gradually reducing its reliance on debt to finance its operations and investments, moving towards a more balanced capital structure. A lower ratio implies that a smaller proportion of the company's capital is derived from debt, which can reduce financial risk and vulnerability to interest rate fluctuations.
Overall, the decreasing debt-to-capital ratio for Idexx Laboratories, Inc. indicates positive progress in managing its debt levels and maintaining a healthier capital structure in recent years. However, it is essential to continue monitoring the ratio to ensure sustainable financial health and stability for the company.
Peer comparison
Dec 31, 2023